CURILLOVA, Jana, Maria PECHACOVA, Tereza PADRTOVÁ, Daniel PECHER, Sarka MASCARETTI, Josef JAMPÍLEK, Ludmila PASKOVA, Frantisek BILKA, Gustav KOVAC and Ivan MALIK. Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents. Applied sciences. Basel: MDPI, 2021, vol. 12, No 1, p. 1-20. ISSN 2076-3417. Available from: https://dx.doi.org/10.3390/app12010300.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents
Authors CURILLOVA, Jana (703 Slovakia), Maria PECHACOVA (703 Slovakia), Tereza PADRTOVÁ (203 Czech Republic, belonging to the institution), Daniel PECHER (703 Slovakia), Sarka MASCARETTI (203 Czech Republic), Josef JAMPÍLEK (203 Czech Republic), Ludmila PASKOVA (703 Slovakia), Frantisek BILKA (703 Slovakia), Gustav KOVAC (703 Slovakia) and Ivan MALIK (703 Slovakia, guarantor).
Edition Applied sciences, Basel, MDPI, 2021, 2076-3417.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30107 Medicinal chemistry
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.838
RIV identification code RIV/00216224:14160/21:00124261
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.3390/app12010300
UT WoS 000752599900001
Keywords in English drug development; N-arylpiperazines; mycobacteria; electronic properties; lipophilicity; cytotoxicity; structure-activity
Tags rivok, ÚChL
Tags International impact, Reviewed
Changed by Changed by: PharmDr. Tereza Padrtová, Ph.D., učo 258420. Changed: 16/3/2022 13:39.
Abstract
This research focused on a three-step synthesis, analytical, physicochemical, and biological evaluation of hybrid molecules 6a-g, containing a lipophilic 3-trifluoromethylphenyl moiety, polar carbamoyloxy bridge, 2-hydroxypropan-1,3-diyl chain and 4-(substituted phenyl)-/4-diphenylmethylpiperazin-1-ium-1-yl fragment. The estimation of analytical and physicochemical descriptors (m/z(measured) via HPLC-UV/HR-MS, log epsilon(2 (Ch-T)) from UV/Vis spectrophotometry and log k(w) via RP-HPLC) as well as in vitro antimycobacterial and cytotoxic screening of given compounds were carried out (i.e., determination of MIC and IC50 values). These highly lipophilic molecules (log k(w) = 4.1170-5.2184) were tested against Mycobacterium tuberculosis H37Ra ATCC 25177 (Mtb H37Ra), M. kansasii DSM 44162 (MK), M. smegmatis ATCC 700084 (MS), and M. marinum CAMP 5644 (MM). The impact of the 6a-g set on the viability of human liver hepatocellular carcinoma (HepG2) cells was also investigated. 1-[2-Hydroxypropyl-{(3-trifluoromethyl)- phenyl}carbamoyloxy]-4-(3,4-dichlorophenyl)piperazin-1-ium chloride (6e) and 1-[2-hydroxy- propyl-{(3-trifluoromethyl)phenyl}carbamoyloxy]-4-(4-diphenylmethyl)piperazin-1-ium chloride (6g) most effectively inhibited the growth of Mtb H37Ra (MIC < 3.80 mu M). The substance 6g also showed interesting activity against MM (MIC = 8.09 mu M). All obtained data served as input values for structure-activity relationship evaluations using statistical principal component analysis. In fact, the toxicity of both 6e (IC50 = 29.39 mu M) and 6g (IC50 = 22.18 mu M) in HepG2 cells as well as selectivity index (SI) values (SI < 10.00) prevented to consider these promising antimycobacterials safe.
PrintDisplayed: 23/8/2024 15:17